Individual Patient Expanded Access to CA102N

NCT05274204 · clinicaltrials.gov ↗

TEMPORARILY_NOT_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Colorectal Cancer (mCRC)

Interventions

DRUG: CA102N

Sponsor

Holy Stone Healthcare Co., Ltd